A study was conducted to assess the efficacy of Tapinarof, a topical therapeutic aryl hydrocarbon receptor modulating agent (TAMA), for the treatment of atopic dermatitis and psoriasis. Improvement of symptom severity in those who received the treatment was examined.
Read more at the Journal of the American Academy of Dermatology.